# The LAVA (Lateral Flow Antigen Validation and Applicability) 2 Study for COVID-19

> **NCT05614427** · NA · COMPLETED · sponsor: **Alder Hey Children's NHS Foundation Trust** · enrollment: 449 (actual)

## Conditions studied

- SARS-CoV-2 Infection

## Interventions

- **DIAGNOSTIC_TEST:** Innova Lateral Flow Test

## Key facts

- **NCT ID:** NCT05614427
- **Lead sponsor:** Alder Hey Children's NHS Foundation Trust
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-03-26
- **Primary completion:** 2021-12-20
- **Final completion:** 2022-04-20
- **Target enrollment:** 449 (ACTUAL)
- **Last updated:** 2022-11-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05614427

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05614427, "The LAVA (Lateral Flow Antigen Validation and Applicability) 2 Study for COVID-19". Retrieved via AI Analytics 2026-07-18 from https://api.ai-analytics.org/clinical/NCT05614427. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*